Related Experiment Video
Updated: Feb 27, 2026

A Mouse Model of Mechanotransduction-driven, Human-like Hypertrophic Scarring
Published on: November 29, 2024
Current Therapeutic Approach to Hypertrophic Scars
Zrinka Bukvić Mokos1, Anamaria Jović1, Lovorka Grgurević2
1Department of Dermatology and Venereology, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
Hypertrophic scars (HSs) lack effective treatments due to poorly understood formation mechanisms. Targeting extracellular matrix components, like bone morphogenetic proteins, offers a promising new therapeutic strategy for improved wound healing and scar reduction.
Area of Science:
- Dermatology
- Wound Healing
- Regenerative Medicine
Background:
- Abnormal scarring, particularly hypertrophic scars (HSs), presents significant aesthetic, functional, and psychological challenges.
- Current understanding of HS formation mechanisms is incomplete, hindering the development of satisfactory prevention and treatment options.
- Existing therapies are often empirical, yielding unreliable and unpredictable outcomes for impaired skin healing.
Purpose of the Study:
- To review current therapeutic approaches and emerging strategies for managing hypertrophic scars.
- To highlight the need for individualized treatment plans based on scar evaluation and patient expectations.
- To explore novel therapeutic avenues targeting specific molecular mechanisms for effective scar management.
Main Methods:
- Review of current literature on hypertrophic scar pathophysiology and treatment modalities.
- Analysis of established and experimental therapeutic options, including combination therapies.
- Exploration of emerging strategies focusing on the extracellular matrix and molecular targets like bone morphogenetic proteins.
Main Results:
- Combination therapy (steroid injections, 5-fluorouracil, pulsed-dye laser) appears most effective among current options.
- No single current treatment reliably overcomes impaired skin healing in hypertrophic scars.
- Targeting extracellular matrix components, particularly through modulation of bone morphogenetic proteins, shows potential for new therapeutic approaches.
Conclusions:
- Individualized treatment for hypertrophic scars is crucial, integrating scar assessment, patient expectations, and evidence-based guidelines.
- There is a significant unmet need for targeted therapies with clarified mechanisms of action for effective hypertrophic scar prevention and treatment.
- Modulating extracellular matrix, specifically bone morphogenetic proteins, represents a promising frontier for achieving functionally and cosmetically acceptable scar outcomes.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Overview of Regeneration and Repair
Regeneration
All animals have varying degrees of...

